Table 2 Laboratory and echocardiographic values before LVAD implantation in the two groups. From: Reversibility of fixed pulmonary hypertension in left.

Slides:

Advertisements

Similar presentations

Fig.1 Complexity of the surgeries according to BAS. Histogram.

Advertisements

Figure 1: Animal preparation; a modified Glenn shunt was created between the SVC and the main pulmonary artery. A left ventricular assist device was implanted.

Fig. 1. TGF results in different group

Table 1 Cause of death for arrested organ donors

Fig. 3 Overall and disease-free survival of single-zone metastasis group according to the number of stations involved. No significant differences were.

Figure 1 Patients outside of target international normalized ratio range by time point and management strategy. All values are expressed as percentages.

Fig. 1. Patient transferred to ICU with IABP inserted surgically through left axillary artery approached at deltoido-pectoralis groove (a). Correct position.

Figure 1: Forest plots. M-H: Mantel-Haenszel test; CI: confidence interval; SD: standard deviation; IV: inverse variance. Suction on chest drains following.

Table 1 Patient characteristics

Fig. 1 Diagram of method C for bronchial closure

Figure 2: The Medical Imaging Projection System projecting the real-time fluorescent image on the surface of the lung during surgery (left). The cut surface.

Fig. 1 Clinical model of coronary collateral flow

Table 1 Staging of resected tumours of the oesophagus

Fig. 4 The blood path conversion to VAD by relocating the tubing clamps. Stasis in the oxygenator is avoided by recirculating its volume, thus allowing.

Figure 1 Representative transoesophageal echocardiographic images of ventricular fibrillation during cardiopulmonary bypass. (A) Mid-oesophageal aortic.

Figure 1: Correlation of plasma ET-1 levels with LAD in patients with mitral valve disease. r is Pearson’s correlation coefficient. ET-1: endothelin 1;

Table 1 Baseline characteristics of mitral valve operated patientsaaAF, atrial fibrillation; LA, left atrium; LVEDD, left ventricular end-diastolic.

Left ventricular assist devices decrease fixed pulmonary hypertension in cardiac transplant candidates Daniel Zimpfer, MD, Philipp Zrunek, MS, Wilfried.

Table 1 Comparison of perioperative patient characteristics by groups

Fig. 1 Log-rank test comparing survival in patients undergoing surgical repair with those treated with TEVAR. Black line: TEVAR; grey line: surgical repair.

Table 1 Hospital mortality

Figure 1 Degrees of major and minor pulmonary fissure completeness.

Figure 1: IPW-adjusted cumulative incidence function of cardiac death at 12 years, with non-cardiac death as competing risk. IPW: inverse probability of.

From: Long-term respiratory functional results after pneumonectomy

Table 2: Baseline characteristicsa of non-survivors and survivors and univariate logistic models predicting 30-day mortality From: The association.

Fig. 1 Protocol for oral sildenafil administration for persistent postoperative pulmonary hypertension in paediatric patients. Each dose was given via.

Table 1 Baseline patient characteristics

Table 1 Recipient’s characteristics.

Figure 3: Mean gradient according to valve size, 6 weeks after surgery

Fig. 3 Summary estimates of the relative risks for the different surgical techniques for late mortality. Comparing the two main techniques, EVR showed.

Table 1 The 5 stages of constructing a BET

Left ventricular assist system as a bridge to myocardial recovery

The RECOVER I: A multicenter prospective study of Impella 5

Marcel Ricklefs, MD, Jasmin S. Hanke, MD, Günes Dogan, MD, L

Left ventricular assist devices decrease fixed pulmonary hypertension in cardiac transplant candidates Daniel Zimpfer, MD, Philipp Zrunek, MS, Wilfried.

New anticoagulant coatings and hemostasis assessment tools to avoid complications with pediatric left ventricular assist devices Daniel C. Leslie, PhD,

Factors Influencing HLA Sensitization in Implantable LVAD Recipients

Effects on pre- and posttransplant pulmonary hemodynamics in patients with continuous-flow left ventricular assist devices Ranjit John, MD, Kenneth Liao,

Implantable Continuous-Flow Right Ventricular Assist Device: Lessons Learned in the Development of a Cleveland Clinic Device Kiyotaka Fukamachi, MD,

BVS5000 support after cardiac transplantation

Elucidating the intricate mechanisms of gastrointestinal bleeding in a continuous-flow left ventricular assist device will lead to future therapeutic.

Initial Clinical Experience With the Symphony Heart Assist System

Clinical Experience With the MEDOS HIA-VAD System in Infants and Children: A Preliminary Report Wolfgang Konertz, MD, PhD, Holger Hotz, MD, Martin Schneider,

Ventricular assist device programs: design and function

Expanding left ventricular assist device use to patients with disabilities: The role of assistive technology Juan A. Crestanello, MD The Journal of.

Discussions in Cardiothoracic Treatment and Care: Mechanical Circulatory Support Left Ventricular Assist Device Therapy for Patients With Advanced Heart.

Should Patients 60 Years and Older Undergo Bridge to Transplantation With Continuous-Flow Left Ventricular Assist Devices? Jeremiah G. Allen, MD, Arman.

Neal A. Chatterjee et al. JCHF 2014;2:

Abdul Rahman Dakkak, MD, Angelo M. Dell'Aquila, MD, Juergen R

Right ventricular failure after cardiac surgery: Why can't right ventricular assist device support fix the problem? Francis D. Pagani, MD, PhD The Journal.

Successful combined procedure of HeartMate II left ventricular assist device implantation and minimally invasive transapical aortic valve replacement

William L. Holman, MD, James K. Kirklin, MD, David C

Trends in LVAD implantation rates among the Medicare population from 2004 to Trends in LVAD implantation rates among the Medicare population from.

Mo1157 ENDOSCOPIC MANAGEMENT AND OUTCOMES OF GASTROINTESTINAL BLEEDING IN PATIENTS WITH LEFT VENTRICULAR ASSIST DEVICE (LVAD) Noemi J. Baffy, Jennifer.

Early Outcomes With Marginal Donor Hearts Compared With Left Ventricular Assist Device Support in Patients With Advanced Heart Failure Erin M. Schumer,

Jay K. Bhama, MD, Utsav Bansal, BS, Daniel G. Winger, MS, Jeffrey J

Left ventricular assist device implantation after acute anterior wall myocardial infarction and cardiogenic shock: A two-center study Nicholas C. Dang,

Is severe right ventricular failure in left ventricular assist device recipients a risk factor for unsuccessful bridging to transplant and post-transplant.

Preoperative risk factors for right ventricular failure after implantable left ventricular assist device insertion Kiyotaka Fukamachi, MD, PhD, Patrick.

Kaplan–Meier survival curves for baseline cardiac magnetic resonance imaging variables according to the median value in patients with pulmonary hypertension.

Postoperative atrial fibrillation is not an innocuous arrhythmia in patients with left ventricular assist devices Cipriano Abad, MD, PhD, FEBS (Hon,

James W. Long, MD, PhD, Aaron H. Healy, BS, Brad Y

Optimal timing of cardiac transplantation after ventricular assist device implantation James S Gammie, MD, Leah B Edwards, PhD, Bartley P Griffith, MD,

Seeing is believing: A call for routine early postoperative hemodynamic transesophageal echocardiography monitoring after left ventricular assist device.

Late Aortic Insufficiency Related to Poor Prognosis During Left Ventricular Assist Device Support Koichi Toda, MD, PhD, Tomoyuki Fujita, MD, Keitaro.

Annetine C. Gelijns, PhD, Alexandra F. Richards, BS, Deborah L

Gastrointestinal bleeding after left ventricular assist device implantation: It is all about the platelets Juan A. Crestanello, MD The Journal of Thoracic.

Nosocomial bloodstream infections in patients with implantable left ventricular assist devices Steven M Gordon, MD, Steven K Schmitt, MD, Micah Jacobs,

Significance of Postoperative Acute Renal Failure After Continuous-Flow Left Ventricular Assist Device Implantation Jamil Borgi, MD, Athanasios Tsiouris,

Randomized, Double-Blind Trial of Inhaled Nitric Oxide in LVAD Recipients With Pulmonary Hypertension Michael Argenziano, Asim F Choudhri, Nader Moazami,

Presentation transcript:

Table 2 Laboratory and echocardiographic values before LVAD implantation in the two groups. From: Reversibility of fixed pulmonary hypertension in left ventricular assist device support recipients Eur J Cardiothorac Surg. 2011;40(4):971-977. doi:10.1016/j.ejcts.2011.01.019 Eur J Cardiothorac Surg | © 2011 European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved.European Association for Cardio-Thoracic Surgery

Table 1 Demographic, clinical and hemodynamic parameters before LVAD implantation in the two groups. From: Reversibility of fixed pulmonary hypertension in left ventricular assist device support recipients Eur J Cardiothorac Surg. 2011;40(4):971-977. doi:10.1016/j.ejcts.2011.01.019 Eur J Cardiothorac Surg | © 2011 European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved.European Association for Cardio-Thoracic Surgery

Table 3 Hemodynamic parameters in patients with fixed PH before LVAD implantation (T<sub>1</sub>) and during assist support (T<sub>2</sub>). From: Reversibility of fixed pulmonary hypertension in left ventricular assist device support recipients Eur J Cardiothorac Surg. 2011;40(4):971-977. doi:10.1016/j.ejcts.2011.01.019 Eur J Cardiothorac Surg | © 2011 European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved.European Association for Cardio-Thoracic Surgery

Table 4 Outcome of patients after LVAD implantation in the two groups. From: Reversibility of fixed pulmonary hypertension in left ventricular assist device support recipients Eur J Cardiothorac Surg. 2011;40(4):971-977. doi:10.1016/j.ejcts.2011.01.019 Eur J Cardiothorac Surg | © 2011 European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved.European Association for Cardio-Thoracic Surgery

Table 5 Literature data overview. From: Reversibility of fixed pulmonary hypertension in left ventricular assist device support recipients Eur J Cardiothorac Surg. 2011;40(4):971-977. doi:10.1016/j.ejcts.2011.01.019 Eur J Cardiothorac Surg | © 2011 European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved.European Association for Cardio-Thoracic Surgery